Age Management

Regenerative Medicine for Age Management
Explore regenerative medicine research and evidence-based strategies to help support healthy aging.
Content Review: Michael Healey, M.Ed., C.A.S. Last Updated: September 2026
Understanding the Science of Aging
Aging is a gradual biological process that affects every organ and tissue over time. Changes in cellular repair, energy production, inflammation, hormone signaling, muscle mass, bone density, skin structure, and nervous-system function can all contribute to how people feel and function as they get older.
Aging itself is not a disease, and no treatment has been shown to stop or reverse normal human aging. However, healthy-aging strategies can help preserve function, reduce disease risk, and support quality of life. Regenerative medicine research is also examining whether cell-based and cell-derived approaches may influence specific age-related conditions.
How Aging Affects the Body
- Changes in vision or hearing
- Reduced muscle mass, strength, or physical endurance
- Joint stiffness or slower recovery after activity
- Changes in sleep quality or energy levels
- Skin thinning, dryness, wrinkles, or reduced elasticity
- Changes in memory, processing speed, or concentration
- Bladder, bowel, or sexual-health changes
- Greater vulnerability to illness, injury, or physical stress
These changes do not occur at the same rate in everyone. Genetics, chronic medical conditions, physical activity, nutrition, sleep, tobacco and alcohol exposure, medications, social factors, and other health behaviors all influence how aging affects the body.
Traditional Approaches to Age Management
Most established age-management strategies focus on preserving physical function, preventing or treating chronic disease, maintaining healthy body composition, and addressing specific symptoms when appropriate.
Standard Health and Wellness Strategies
- Regular physical activity: Aerobic exercise, resistance training, balance work, and flexibility exercises can help maintain strength, cardiovascular health, mobility, and independence.
- Nutrition: Adequate protein, fiber, vitamins, minerals, and an overall nutrient-dense eating pattern can support muscle, bone, metabolic, and cardiovascular health.
- Sleep and stress management: Consistent sleep, evaluation of persistent sleep problems, and stress-reduction strategies can support overall health and recovery.
- Preventive care: Routine medical care, vaccinations, cancer screening, cardiovascular risk management, and attention to vision, hearing, bone health, and fall prevention remain central to healthy aging.
- Management of chronic conditions: Blood pressure, diabetes, cholesterol, arthritis, mood disorders, and other conditions should be treated using established medical care.
- Hormone therapy when clinically indicated: Hormone replacement or optimization may be appropriate for selected patients after individualized medical evaluation, but it is not a general anti-aging treatment.
- Cosmetic and dermatologic treatments: Procedures such as neuromodulators, fillers, resurfacing, or other dermatologic treatments may address appearance-related concerns without changing the underlying biology of aging.
Supplements are sometimes marketed for anti-aging or longevity, but evidence varies widely by product. Supplements should be reviewed with a healthcare professional because they can interact with medications or be inappropriate for certain medical conditions.
A Modern Regenerative Approach
Regenerative medicine research is exploring mesenchymal stromal cells (MSCs), extracellular vesicles such as exosomes, and other biologic approaches in specific age-related conditions. Current human research has included frailty, neurodegenerative disease, skin aging, and other areas. These approaches are not interchangeable, and findings in one population should not be generalized to another. A study in adults with frailty, for example, does not establish that the same treatment improves health, energy, cognition, or longevity in otherwise healthy adults.
Why Stem Cells Are Being Studied
- Whether cell-based therapies can be administered safely in older adults
- Changes in physical function, mobility, strength, and quality of life
- Inflammatory and immune-system signaling associated with frailty and age-related disease
- Brain-volume, cognitive, and neuroinflammatory measures in neurodegenerative conditions
- Skin hydration, elasticity, wrinkles, pigmentation, and tissue remodeling
- Which cell sources, doses, delivery methods, and treatment schedules warrant larger controlled trials
Note: Stem cell and exosome products are not FDA-approved for general age management or for reversing normal aging. The FDA has also stated that no exosome products are FDA-approved. Regenerative medicine products should be evaluated according to the specific product, indication, clinical evidence, regulatory status, and treatment protocol being considered.
How Regenerative Medicine for Age Management Is Being Studied
Human studies in this area generally focus on defined medical populations rather than healthy adults seeking anti-aging treatment. Clinical trials have evaluated MSCs in older adults with frailty and in people with age-related diseases such as Alzheimer’s disease. Dermatology studies have evaluated topical or procedure-assisted extracellular-vesicle products for selected skin-aging outcomes. Researchers commonly measure safety, quality of life, physical performance, cognitive assessments, imaging, inflammatory biomarkers, and skin-related outcomes. Because these studies involve different products and patient groups, results should be interpreted within the condition and protocol that were actually studied. At present, regenerative medicine for age management should be considered investigational and product-specific.
Recent Human Studies on Umbilical Cord MSCs and Exosomes
2025: Laromestrocel Trial Met Its Safety Endpoint and Reported Signals in Mild Alzheimer’s Disease
Allogeneic Mesenchymal Stem Cell Therapy With Laromestrocel in Mild Alzheimer’s Disease: A Randomized Controlled Phase 2a Trial — Read Study
This randomized, double-blind, placebo-controlled phase 2a trial evaluated laromestrocel, a bone-marrow-derived allogeneic mesenchymal cell therapy, in 49 treated participants with mild Alzheimer’s disease. The study met its primary safety endpoint, with similar rates of treatment-emergent serious adverse events across groups and no reported infusion-related reactions, hypersensitivity reactions, or amyloid-related imaging abnormalities. At 39 weeks, investigators also reported favorable signals in several secondary and exploratory measures, including a composite Alzheimer’s disease score, selected cognitive and daily-living measures, whole-brain volume, hippocampal volume, and neuroinflammation imaging. These findings provide encouraging phase 2a evidence supporting continued clinical development of laromestrocel for mild Alzheimer’s disease. They should not be interpreted as evidence that MSC therapy slows normal cognitive aging or provides a general anti-aging effect in healthy adults.
2024: Randomized Frailty Trial Reported Improvements in Quality of Life and Physical Performance
Safety and Efficacy of Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in the Treatment of Patients With Aging Frailty: A Phase I/II Randomized, Double-Blind, Placebo-Controlled Study — Read Study
This phase I/II trial randomly assigned 30 adults ages 60 to 80 with aging frailty to receive two intravenous infusions of human umbilical-cord-derived MSCs or placebo one month apart. At six months, the MSC group showed a greater improvement in the physical-component score of the SF-36 quality-of-life measure than the placebo group, along with favorable differences in EQ-VAS scores, timed-up-and-go performance, grip strength, and inflammatory markers including TNF-α and IL-17. The 4-meter walking-time difference favored MSC treatment but was not statistically significant, and no serious adverse events were observed. The randomized, placebo-controlled design and favorable six-month safety and functional findings make this an important human study of MSC therapy in aging frailty, though larger studies are still needed to confirm the magnitude, durability, and clinical significance of these effects.
2024: Review Summarized Early Exosome Research in Cosmetic Dermatology
Clinical Applications of Exosomes in Cosmetic Dermatology — Read Review
This 2024 review evaluated published human and animal research on exosomes in regenerative and cosmetic dermatology, identifying four prospective clinical trials focused on skin rejuvenation while emphasizing that clinical evidence remains limited. One study summarized in the review was a 2023 prospective, randomized, split-face study involving 28 adults with facial skin aging, in which one side of the face received microneedling with a human adipose-stem-cell-derived exosome-containing solution while the other side received microneedling with saline. At 12 weeks, the exosome-treated side showed greater improvements in wrinkle measurements, elasticity, hydration, melanin index, and histologic collagen and elastic-fiber density, with mild and temporary reported adverse effects. These early findings support continued investigation of extracellular-vesicle products in cosmetic dermatology, though the review cautioned that product sourcing and preparation are not standardized and exosome products have not received FDA approval.

Considering Regenerative Medicine for Age Management
For adults interested in maintaining function and wellness as they age, the first step is a medical evaluation focused on evidence-based healthy-aging strategies and any specific symptoms or conditions that need treatment. A consultation can help review:
- Your medical history, medications, and current health concerns
- Physical activity, nutrition, sleep, and other lifestyle factors
- Cardiovascular, metabolic, bone, cognitive, and functional health
- Whether hormone therapy or other established treatments are medically appropriate
- The evidence for any specific regenerative product or protocol being considered
- FDA status, potential risks, costs, and whether an investigational treatment is being offered through an appropriately regulated clinical trial
Regenerative medicine should not replace established preventive care or treatment for diagnosed medical conditions. At Stemedix, our focus is on patient education, individualized evaluation, and helping people understand emerging regenerative research in the context of their broader health and wellness goals.
Interested in learning more? Contact us to schedule a consultation and find out if regenerative medicine for age management may be appropriate to discuss with your healthcare provider.
Medical Disclaimer
This page is for educational purposes only and does not constitute medical advice.
Stem cell, exosome, and other regenerative medicine therapies for general age management are not FDA-approved for this use, and findings from studies in frailty, Alzheimer’s disease, or cosmetic dermatology do not establish benefits for normal aging or longevity in healthy adults.
Always consult a qualified healthcare professional before starting, stopping, or modifying any medical, hormone, supplement, cosmetic, or regenerative treatment.
References
- Rash BG. et al. Allogeneic Mesenchymal Stem Cell Therapy With Laromestrocel in Mild Alzheimer’s Disease: A Randomized Controlled Phase 2a Trial. Nature Medicine., 2025. Full Text
- Zhu Y. et al. Safety and Efficacy of Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in the Treatment of Patients With Aging Frailty: A Phase I/II RCT. Stem Cell Research & Therapy., 2024. Full Text
- Clinical Applications of Exosomes in Cosmetic Dermatology. Skin Health and Disease., 2024. Full Text
- Park GH. et al. Efficacy of Combined Treatment With Human Adipose Tissue Stem Cell-Derived Exosome-Containing Solution and Microneedling for Facial Skin Aging: A 12-Week Prospective, Randomized, Split-Face Study. Journal of Cosmetic Dermatology., 2023. Full Text
U.S. Food and Drug Administration. Important Patient and Consumer Information About Regenerative Medicine Therapies.
Speak with a Care Coordinator today for a more accurate assessment of your condition and therapy options.
Forward-Thinking Medicine for Age Management
Contact us today and let Stemedix provide a professional service accompanied by one of our Care Coordinators to ensure you have the best experience possible!
